A comparison of iatrogenic injury studies in Australia and the USA II: reviewer behaviour and quality of care

被引:86
作者
Runciman, WB
Webb, RK
Helps, SC
Thomas, EJ
Sexton, EJ
Studdert, DM
Brennan, TA
机构
[1] Royal Adelaide Hosp, Dept Anaesthesia & Intens Care, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Anaesthesia & Intens Care, Adelaide, SA, Australia
[3] Australian Patient Safety Fdn, Adelaide, SA, Australia
[4] Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Harvard Univ, Sch Publ Hlth, Dept Hlth Care Policy & Management, Boston, MA USA
关键词
adverse events; complications; iatrogenic injury; medical record review; quality of care;
D O I
10.1093/intqhc/12.5.379
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To better understand the remaining three-fold disparity between adverse event (AE) rates in the Quality in Australia Health Care Study (QAHCS) and the Utah-Colorado Study (UTCOS) after methodological differences had been accounted for. Setting. Iatrogenic injury in hospitalized patients in Australia and America. Design. Using a previously developed classification, all AEs were assigned to 98 exclusive descriptive categories and the relative rates compared between studies; they were also compared with respect to severity and death. Main outcome measures. The distribution of AEs amongst the descriptive and outcome categories. Results. For 38 categories, representing 67% of UTCOS and 28% of QAHCS AEs, there were no statistically significant differences. For 33, representing 31% and 69% respectively, there was seven times more AEs in QAHCS than in UTCOS. Rates for major disability and death were very similar (1.7% and 0.3% of admissions for both studies) but the minor disability rate was six times greater in QAHCS (8.4% versus 1.3%). Conclusions. A similar 2% core of serious AEs was found in both studies, but for the remaining categories six to seven times more AEs were reported in QAHCS than in UTCOS. We hypothesize that this disparity is due to different thresholds for admission and discharge and to a greater degree of under-reporting of certain types of problems as AEs by UTCOS than QAHCS reviewers. The biases identified were consistent with, and appropriate for, the quite different aims of each study. No definitive difference in quality of care was identified by these analyses or a literature review.
引用
收藏
页码:379 / 388
页数:10
相关论文
共 26 条
[1]  
[Anonymous], PRIMARY INTENTION
[2]  
BARBENEL JC, 1977, LANCET, V2, P548
[3]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[4]   THE IMPACT OF RESEARCH QUALITY AND STUDY DESIGN ON EPIDEMIOLOGIC ESTIMATES OF THE EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON UPPER GASTROINTESTINAL-TRACT DISEASE [J].
BOLLINI, P ;
RODRIGUEZ, LAG ;
GUTTHANN, SP ;
WALKER, AM .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) :1289-1295
[5]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[6]  
BROOK RH, 1988, LANCET, V1, P750
[7]  
*CDC, 1997, EPIINFO6
[8]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[9]  
GIRVIN J, 1989, NURS TIMES, V85, P64
[10]   VARIABILITY IN THE RISK OF MAJOR GASTROINTESTINAL COMPLICATIONS FROM NONASPIRIN NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
HENRY, D ;
DOBSON, A ;
TURNER, C .
GASTROENTEROLOGY, 1993, 105 (04) :1078-1088